Two recent articles – one in the Washington Post and one in the Wall Street Journal – have raised the spectre of how smartphone medical apps imply an imminent trainwreck between today’s rapid-pace innovation and last century’s slower-going FDA regulation … Continue reading at ComplianceZen.com →